ASXSF Elysee Development Corp (PK)

Remedent, Inc. (OTCBB: REMI) a leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products, announced today that it has opened an office in the United States to market and sell its products. The company's headquarters is located in Deurle, Belgium, with an additional office in Singapore. Remedent, Inc. has hired industry veterans to manage its US-based office. Judd D. Hoffman, Scott G. Juhl, Mark E. Sernatinger and Stacey J. Ammons are charged with developing the Remedent brand globally and specifically the MetaTray in the US market. Their combined years of experience and understanding of the dental market provide an excellent opportunity for Remedent to build its footprint domestically and internationally. Judd D. Hoffman, Vice President of Worldwide Sales and Operations, commented, "We are happy to be part of the Remedent, Inc. family. Our US office is now fully operational with a committed staff and consultants charged with building the Remedent brand across the globe. With a US presence, we are reinforcing our commitment and relationships with our global partners." Guy De Vreese, Chairman of Remedent, Inc, said, "We are happy to have Judd and his team as part of our organization. They bring understanding and clarity of the dental marketplace, and a desire to expand MetaTray and the Remedent Brand across the United States." Remedent, Inc. (OTC Bulletin Board: REMI) strives to be a world leader in the research and development, manufacturing and marketing of oral care and cosmetic dentistry products. Remedent products are renowned for their technological superiority and ease-of-use. Based in Deurle, Belgium and El Segundo, CA, Remedent has successfully researched, developed and manufactured all of its own products. These products are now distributed in more than 35 countries worldwide. Remedent consists of two divisions: one that serves the dental community and one that is focused on the over-the-counter consumer market. Visit www.Metatray.com/usa for further information. Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the consummation and the successful integration of proposed acquisitions, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's financial results, backlog, critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstance.